XML 18 R9.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated statements of cash flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Operating activities    
Net loss $ (128,617) $ (83,274)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Provision for expected credit losses 2  
Inventory write-down 7  
Depreciation and amortization expenses 2,107 1,563
Amortization of deferred income (156) (156)
Share-based compensation 13,427 9,294
Share of loss from equity method investment 406 316
Loss on disposal of property and equipment 1 10
Noncash lease expenses 2,114 1,037
Changes in operating assets and liabilities:    
Accounts receivable (3,235) (2,393)
Inventories (571) (137)
Prepayments and other current assets (948) (361)
Long term deposits (335) 167
Value added tax recoverable (2,422) (3,126)
Accounts payable 9,732 (9,707)
Other current liabilities 4,697 4,027
Operating lease liabilities (1,539) (1,051)
Deferred income 13,011 607
Net cash used in operating activities (92,319) (83,184)
Cash flows from investing activities:    
Purchases of short-term investments (205,000) (201,600)
Proceeds from maturity of short-term investments 200,000 100,350
Purchase of property and equipment (1,303) (4,077)
Purchase of intangible assets (218) (690)
Net cash used in investing activities (6,521) (106,017)
Cash flows from financing activities:    
Proceed from short-term borrowings   2,954
Repayment of short-term borrowings (2,130) (739)
Proceeds from exercises of stock options 3,075 304
Proceeds from issuance of ordinary shares upon public offerings 281,295 216,200
Payment of public offering costs (740) (839)
Net cash provided by financing activities 281,500 217,880
Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash 12 (28)
Net increase in cash, cash equivalents and restricted cash 182,672 28,651
Cash, cash equivalents and restricted cash - beginning of the period 76,442 62,952
Cash, cash equivalents and restricted cash - end of the period 259,114 91,603
Supplemental disclosure on non-cash investing and financing activities:    
Payables for purchase of property and equipment 984 268
Payables for public offering costs   150
Supplemental disclosure of cash flow information:    
Total cash and cash equivalents and restricted cash 259,114 91,603
Interest expense paid $ 122 $ 137